Literature DB >> 21544985

[Cardiovascular complications of phosphodiesterase-5 inhibitors].

Wojciech Dworzański1, Anna Jaskólska, Michał Szumiło, Anna Switalska, Franciszek Burdan.   

Abstract

Phosphodiesterase type 5 inhibitors increase the intracellular level of cyclic guanosine monophosphate that is a potent nitric oxide dependent vasodilatation and antiproliferation agent. Unlike vardenafil and tadalafil which are prescribed in the erectile dysfunction, sildenafil is also used in a treatment of the pulmonary arterial hypertension, both congenital and acquired. The drug administration may let to various side effects such epistaxis, headache, flushing, eye problem including blurry vision, retinal hemorrhage and nonarteritic anterior ischemic optic neuropathy. It may be also complicated by high reduction of blood pressure and syncope especially in patients concomitantly treated with oral nitrate medications. High caution should be also taken in patients with a heart failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544985

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  2 in total

1.  Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case.

Authors:  Farshid S Garmaroudi; Diane E Handy; Yang-Yu Liu; Joseph Loscalzo
Journal:  PLoS Comput Biol       Date:  2016-03-17       Impact factor: 4.475

2.  Intraocular Hemorrhage due to use of Sildenafil in a Patient with Diabetes.

Authors:  Cagri Ilhan; Mehmet Murat Uzel; Mehmet Citirik
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.